Wikipedia -WSS

Wikipedia

author：hotspot 2025-08-26 10:55:20 - browse：31455

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Medical device trials still don't enroll enough women, study finds

WSS

Type 2 diabetes prevention programs work at large scale: study

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Ventyx halts psoriasis drug development after lackluster trial results

Cancer diagnosis changes perspective doctor, former hospital CEO

Carbon Health diabetes program, a test of data

FDA reorg will put new emphasis on investigations, sources say

knowledge

Wikipedia

focus

23andMe had bad news about my health. I wish a person had delivered it

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

The cancer drug shortage isn’t new — and neither are the solutions

Study suggests Covid rebound is far more common with Paxlovid than without

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Bright Health sells Medicare Advantage business to Molina

A letter from the executive editor: STAT UnitedHealth investigation

ChatGPT in medicine: STAT answers readers' burning questions

Report captures long Covid’s disabling effects and policy challenges

focus

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

FDA reorg will put new emphasis on investigations, sources say

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

NIH tests clinical research in primary care with $30 million program

My daughter's legacy lives on through her writing, phage therapy

5 takeaways from STAT's examination of Zynex Medical

leisure time

knowledge

explore

leisure time